|
|
|
|
|
|
|
|
|
07.10.26 - 13:45
|
Exklusiv: Gilead Sciences plant HSV-Weltpremiere am 24. Oktober (Sharedeals)
|
|
|
Am 24. Oktober könnte Gilead auf der IDWeek 2026 in Washington erstmals zeigen, wie groß man das HSV-Geschäft tatsächlich denkt. Nach exklusiven sharedeals.de-Informationen plant Gilead an diesem Tag Updates zu seinem von Assembly Biosciences einlizenzierten HSV-Programm. Hinter bloßen Studiendaten könnte eine wesentlich größere Story stehen: der Aufbau einer neuen Multi-Milliarden-Franchise neben HIV. Die IDWeek ist […]
The post Exklusiv: Gilead Sciences plant HSV-Weltpremiere am 24. Oktober first appeared on sharedeals.de....
|
|
|
07.10.26 - 11:48
|
Gilead Sciences signs five-year DevOps agreement with Cognizant (PBR)
|
|
|
The renewed arrangement will see Cognizant combine its life sciences sector knowledge with technical services to aid Gilead's ongoing development and operational processes. The joint work is intended
The post Gilead Sciences signs five-year DevOps agreement with Cognizant appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
29.09.26 - 15:06
|
Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors (Business Wire)
|
|
|
Sware gains 35 years of pharma technology leadership as life sciences organizations modernize validation for the AI eraBOSTON--(BUSINESS WIRE)--Sware, Inc., the company behind the Res_Q, the AI-powered validation platform, and provider of GxP compliance solutions, today announced the appointment of Mark Hill to its Board of Directors.
Hill has spent more than 35 years leading information and technology across the pharmaceutical and life sciences industry, working with CEOs, boards, and executive teams through growth, disruption, acquisition, and modernization. He is Executive Vice President and Chief Digital & Information Officer at CSL Limited. Before CSL, he was CIO of Gilead Sciences and held senior technology leadership roles at Merck and Schering-Plough. He served as Independent Director of Puppet through its acquisition by Perforce Software and has advised Tricentis, Zapata Quantum, and Iridius.ai. Hill is a United States Army veteran.
His appointment comes as life sciences companies move quickly to...
|
|
|
23.09.26 - 11:00
|
Gilead Sciences und Assembly Bio: Kommt am 13. Oktober der Herpes-Paukenschlag? (Sharedeals)
|
|
|
Bei Gilead Sciences verdichten sich derzeit die Hinweise darauf, dass der Pharmakonzern in den kommenden Jahren das Therapiefeld der Virologie massiv ausbauen und damit die langfristige Abhängigkeit vom HIV-Geschäft minimieren will. Die Hintergründe könnten auch für Anleger spannender kaum sein. Eine neue Stellenanzeige, die langjährige Partnerschaft mit Assembly Biosciences, bereits einlizenzierte Helicase-Primase-Inhibitoren und Aussagen von […]
The post Gilead Sciences und Assembly Bio: Kommt am 13. Oktober der Herpes-Paukenschlag? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
